-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network
Frederick A Curro, Dennis A Robbins, Frederick Naftolin, Ashley C Grill, Don Vena & Louis Terracio
Clinical Trail Perspective: Clinical Investigation
-
Improving patient participation in Parkinsons clinical trials: the experience of the Michael J Fox Foundation
Sohini Chowdhury, Claire C Meunier, Lily Cappelletti & Todd B Sherer
Clinical Trail Perspective: Clinical Investigation
-
Improving patient participation in Parkinsons clinical trials: the experience of the Michael J Fox Foundation
Sohini Chowdhury, Claire C Meunier, Lily Cappelletti & Todd B Sherer
Clinical Trail Perspective: Clinical Investigation
-
Improving patient participation in Parkinsons clinical trials: the experience of the Michael J Fox Foundation
Sohini Chowdhury, Claire C Meunier, Lily Cappelletti & Todd B Sherer
Clinical Trail Perspective: Clinical Investigation
-
Improving patient participation in Parkinsons clinical trials: the experience of the Michael J Fox Foundation
Sohini Chowdhury, Claire C Meunier, Lily Cappelletti & Todd B Sherer
Clinical Trail Perspective: Clinical Investigation
-
Improving patient participation in Parkinsons clinical trials: the experience of the Michael J Fox Foundation
Sohini Chowdhury, Claire C Meunier, Lily Cappelletti & Todd B Sherer
Clinical Trail Perspective: Clinical Investigation
-
Improving patient participation in Parkinsons clinical trials: the experience of the Michael J Fox Foundation
Sohini Chowdhury, Claire C Meunier, Lily Cappelletti & Todd B Sherer
Clinical Trail Perspective: Clinical Investigation
-
Improving patient participation in Parkinsons clinical trials: the experience of the Michael J Fox Foundation
Sohini Chowdhury, Claire C Meunier, Lily Cappelletti & Todd B Sherer
Clinical Trail Perspective: Clinical Investigation
-
Improving patient participation in Parkinsons clinical trials: the experience of the Michael J Fox Foundation
Sohini Chowdhury, Claire C Meunier, Lily Cappelletti & Todd B Sherer
Clinical Trail Perspective: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 9
Acknowledgements: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of eribulin mesylate in the treatment of breast cancer
Carole Gourmelon, Jean Sebastien Frenel,Mario Campone
Review: Clinical Trail Outcomes: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation